Optiscan Imaging (ASX:OIL) is focussed on microscopic imaging technologies for medical markets, using its unique and patented technologies enable high-powered microscopes to be miniaturised and used inside the body.
The technology enables microscopic imaging of up to 1000 times magnification to be achieved.
Doctors can then use this technology to instantly see cellular level details of tissue without the requirement to surgically remove tissue, known as a biopsy.
Optiscan is now preparing to provide an update concerning fundraising, upon finalisation of the arrangements.
The halt will remain in place until the opening of trade on Wednesday 24th September 2014, or earlier of an announcement is made to the market.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.